Following its acquisition by AstraZeneca, MedImmune needed to reposition itself as the international biologics arm of AstraZenca under the MedImmune name. At the same time, MedImmune sought to reinforce and enhance its involvement in the Washington area business community. The company selected Qorvis to assist with important community and industry events, their extensive charitable grants program, and media outreach.